VRS
FOLD

Virginia Retirement Systems’s Amicus Therapeutics FOLD Stock Holding History

Virginia Retirement Systems’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,600
Closed -$313K – 1114
2022
Q4 		$313K Buy
25,600
+4,600
+22% +$51.8K ﹤0.01% 953
2022
Q3 		$219K Buy
+21,000
New +$234K ﹤0.01% 1034
2022
Q1 		$390K Buy
41,200
+300
+0.7% +$2.81K ﹤0.01% 916
2021
Q4 		$472 Sell
40,900
-4,600
-10% -$51.3K ﹤0.01% 872
2021
Q3 		$435K Buy
45,500
+13,900
+44% +$142K ﹤0.01% 811
2021
Q2 		$305K Buy
31,600
+8,500
+37% +$83K ﹤0.01% 921
2021
Q1 		$228K Buy
23,100
+500
+2% +$7.74K ﹤0.01% 1055
2020
Q4 		$522K Buy
22,600
+3,400
+18% +$69.5K 0.01% 831
2020
Q3 		$271K Sell
19,200
-900
-4% -$13.1K ﹤0.01% 955
2020
Q2 		$303K Buy
+20,100
New +$245K ﹤0.01% 947

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Virginia Retirement Systems's FOLD Position: Q1 2023 in Review

Virginia Retirement Systems sold out of Amicus Therapeutics (FOLD) in Q1 2023, closing a stake of 25,600 shares — an estimated $313K sold.

Virginia Retirement Systems first reported a position in FOLD in Q2 2020 and held it in 10 quarters. The position peaked at $522K in Q4 2020. 226 funds tracked by Wall St. Rank hold FOLD as of Q1 2023.

  • Virginia Retirement Systems reported no remaining Amicus Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Virginia Retirement Systems sold 25,600 Amicus Therapeutics shares in Q1 2023, an estimated $313K.
  • Virginia Retirement Systems first reported a position in Amicus Therapeutics in Q2 2020 and held it in 10 quarters.
  • Virginia Retirement Systems's Amicus Therapeutics position peaked at $522K in Q4 2020.
  • 226 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2023.

Based on Virginia Retirement Systems's 13F filing for Q1 2023, filed 11 Jul 2023.